Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mark, Niosi"'
Autor:
David Rodrigues, Mark Niosi, Heather Eng, Christopher Healy, Sarah Lazzaro, Qingyi Yang, Matthew A. Cerny
Publikováno v:
The Journal of Clinical Pharmacology.
Autor:
Kentaro Futatsugi, Shawn Cabral, Daniel W. Kung, Kim Huard, Esther Lee, Markus Boehm, Jonathan Bauman, Ronald W. Clark, Steven B. Coffey, Collin Crowley, Anne-Marie Dechert-Schmitt, Matthew S. Dowling, Robert Dullea, James R. Gosset, Amit S. Kalgutkar, Kou Kou, Qifang Li, Yajing Lian, Paula M. Loria, Allyn T. Londregan, Mark Niosi, Christine Orozco, John C. Pettersen, Jeffrey A. Pfefferkorn, Jana Polivkova, Trenton T. Ross, Raman Sharma, Ingrid A. Stock, Gregory Tesz, Hanna Wisniewska, Bryan Goodwin, David A. Price
Publikováno v:
Journal of medicinal chemistry. 65(22)
Discovery efforts leading to the identification of ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2) inhibitor that has advanced into clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) with
Autor:
Shawn D. Doran, Jana Polivkova, James A. Southers, Scott W. Bagley, Kim Huard, Dilinie P. Fernando, Manthena V.S. Varma, David A. Beebe, David J. Edmonds, Robert L. Dow, Benjamin A. Thuma, Collin Crowley, William P. Esler, Trenton T. Ross, David A. Tess, Mark Niosi, Amit S. Kalgutkar, Jeffrey A. Pfefferkorn, Norimitsu Shirai, David A. Griffith, Shawn Cabral, Andrew H. Smith, Gregg D. Cappon, Vincent Mascitti, Matthew S. Dowling, Andre Shavnya, David Price, Ayman El-Kattan, Aaron C. Smith, Yi-an Bi, Spiros Liras, Xiaojing Helen Yang, Cathy Préville
Publikováno v:
Journal of Medicinal Chemistry. 63:10879-10896
Preclinical and clinical data suggest that acetyl-CoA carboxylase (ACC) inhibitors have the potential to rebalance disordered lipid metabolism, leading to improvements in nonalcoholic steatohepatitis (NASH). Consistent with these observations, first-
Autor:
Jian Lin, Kimberly Lapham, Ernesto Callegari, Julie Cianfrogna, Christine C. Orozco, Raman Sharma, Mark Niosi, Theunis C. Goosen
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 48(12)
Ertugliflozin is primarily cleared through UDP-glucurosyltransferase (UGT)–mediated metabolism (86%) with minor oxidative clearance (12%). In vitro phenotyping involved enzyme kinetic characterization of UGTs or cytochrome P450 enzymes catalyzing f
Autor:
Kimberly Lapham, Jian Lin, Jonathan J. Novak, Heather Eng, Theunis C. Goosen, Li Di, Amit S. Kalgutkar, Kimberly O. Cameron, Mark Niosi, Christine C. Orozco, Sangwoo Ryu, Keith Riccardi
Publikováno v:
Drug Metabolism and Disposition. 46:1836-1846
6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577) is a direct activator of the human β1-containing adenosine monophosphate-activated protein kinase (ΑMPK) isoforms. The clearance mechanism of PF-06409577 in animal
Autor:
Jill Barber, Zubida M. Al-Majdoub, Jonathan J. Novak, Theunis C. Goosen, Amin Rostami-Hodjegan, Brahim Achour, Alyssa Dantonio, Mark Niosi
Publikováno v:
Drug Metabolism and Disposition. 46:805-812
Quantitative proteomic methods require optimization at several stages, including sample preparation, liquid chromatography-tandem mass spectrometry (LC-MS/MS), and data analysis, with the final analysis stage being less widely appreciated by end-user
Publikováno v:
Bioanalysis. 10:357-368
Aim: An LC–MS/MS assay for the quantitation of liraglutide, a peptide-based injectable glucagon-like peptide-1 receptor agonist, has been developed as a convenient alternative to the enzyme-linked immunosorbent assay, and used to characterize lirag
Autor:
John K. Fallon, Alyssa Dantonio, Theunis C. Goosen, Jill Barber, Philip C. Smith, Amin Rostami-Hodjegan, Mark Niosi, Jonathan J. Novak, Brahim Achour
Publikováno v:
Achour, B, Dantonio, A, Niosi, M, Novak, J J, Fallon, J K, Barber, J, Smith, P C, Rostami-Hochaghan, A & Goosen, T C 2017, ' Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes : Comparison of Two Proteomic Methods and Correlation with Catalytic Activity ', Drug Metabolism and Disposition, vol. 45, no. 10, pp. 1102-1112 . https://doi.org/10.1124/dmd.117.076703
Quantitative characterization of UDP-glucuronosyltransferase (UGT) enzymes is valuable in glucuronidation reaction phenotyping, predicting metabolic clearance and drug-drug interactions using extrapolation exercises based on pharmacokinetic modeling.
Autor:
John Litchfield, Jian Lin, Mark Niosi, Wenyi Hua, Sangwoo Ryu, Keith Riccardi, Rachel E. Kosa, Karen Atkinson, Li Di, Zhenhong Li
Publikováno v:
Drug Metabolism and Disposition. 45:576-580
The ability to predict human liver-to-plasma unbound partition coefficient (Kpuu) is of great importance to estimate unbound liver concentration, develop PK/PD relationships, predict efficacy and toxicity in the liver, and model the drug-drug interac
Autor:
Dilinie P. Fernando, Gary Erik Aspnes, Sophie Y. Lavergne, Daniel W. Kung, Michael Herr, I. D. Pardo, Qifang Li, Norimitsu Shirai, Bryan Goodwin, Suvi T. M. Orr, Jun Zhou, Julie Purkal, Matthew S. Dowling, Kentaro Futatsugi, R. J. Barnes, Declan Flynn, Ahmed M. Shoieb, David Hepworth, T. J. Schmahai, Mark Niosi, W. P. Gorczyca, Kim Huard, John C. Pettersen, Sylvie Perez, Shawn Cabral, James R. Gosset, Theunis C. Goosen
Publikováno v:
MedChemComm. 8:771-779
Small molecule DGAT2 inhibitors have shown promise for the treatment of metabolic diseases in preclinical models. Herein, we report the first toxicological evaluation of imidazopyridine-based DGAT2 inhibitors and show that the arteriopathy associated